Mulpleta (lusutrombopag) — Blue Cross Blue Shield of Oklahoma
Other FDA labeled indications
Initial criteria
- Diagnosis of thrombocytopenia with chronic liver disease
- Baseline platelet count < 50 x 10^9/L prior to therapy
- Scheduled to undergo a procedure with associated risk of bleeding (e.g., gastrointestinal endoscopy, liver biopsy, bronchoscopy, dental procedure)
- Would require platelet transfusion unless platelet counts are increased from baseline